Literature DB >> 16019564

Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome.

Karen Seiter1, Anila Qureshi, Delong Liu, Patricia Galvin-Parton, Muhammad Arshad, Glen Agoliati, Tauseef Ahmed.   

Abstract

Werner's syndrome is an autosomal recessive disorder resulting in premature aging. Most patients die in their fifth decade from malignancies or heart disease. The gene for Werner's syndrome (WRN) encodes a recQ helicase. Cells from patients with Werner's syndrome have increased sensitivity to DNA-damaging drugs in vitro. Here we present a patient with Werner's syndrome who developed severe chemotherapy-induced toxicity during treatment for acute myelogenous leukemia. We propose that lack of WRN resulted in increased sensitivity of the patient's cells to the toxicity of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019564     DOI: 10.1080/10428190500102688

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.

Authors:  Federico Innocenti; Snezana Mirkov; Ramamoorthy Nagasubramanian; Jacqueline Ramírez; Wanqing Liu; Wasim K Bleibel; Sunita J Shukla; Kathleen Hennessy; Gary L Rosner; Edwin Cook; M Eileen Dolan; Mark J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  2008-08-02       Impact factor: 3.333

2.  Clinical utility gene card for: Werner Syndrome--Update 2014.

Authors:  Fuki M Hisama; Christian Kubisch; George M Martin; Junko Oshima
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

3.  Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.

Authors:  Nils W Engel; Simon Schliffke; Ulrich Schüller; Christian Frenzel; Carsten Bokemeyer; Christian Kubisch; Davor Lessel
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

4.  Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN Gene.

Authors:  Beatriz Mendes Awni; Carlos Diego Holanda Lopes; Guilherme Harada; Alessandra Corte Real Salgues; Gilmar de Andrade França; Leonardo de Abreu Testagrossa; Marcelo Araujo Queiroz; Adriano Gonçalves E Silva; Fabio de Oliveira Ferreira; Rodrigo Ramella Munhoz
Journal:  Case Rep Oncol       Date:  2022-03-04

5.  Case Report: A novel WRN mutation in Werner syndrome patient with diabetic foot disease and myelodysplastic syndrome.

Authors:  Huifang Peng; Jie Wang; Yanyun Liu; Haiping Yang; Liping Li; Yujin Ma; Huiqin Zhuo; Hongwei Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

Review 6.  Spectrum and risk of neoplasia in Werner syndrome: a systematic review.

Authors:  Julia M Lauper; Alison Krause; Thomas L Vaughan; Raymond J Monnat
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.